Dr. Mason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106Phone+1 215-829-6088Fax+1 215-829-6104
Education & Training
- Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
- George Washington UniversityFellowship, Hematology and Medical Oncology, 1976 - 1977
- George Washington UniversityResidency, Internal Medicine, 1975 - 1976
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1972 - 1975
- Perelman School of Medicine at the University of PennsylvaniaClass of 1972
Certifications & Licensure
- PA State Medical License 1973 - 2024
- NJ State Medical License 1977 - 2009
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer Start of enrollment: 2007 Feb 28
- Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer Start of enrollment: 2006 Sep 15
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- Join now to see all
Publications & Presentations
PubMed
- 277 citationsCombination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology ...Philip Bonomi, Dianne M. Finkelstein, John C. Ruckdeschel, Ronald H. Blum, M D Green
Journal of Clinical Oncology. 1989-11-01 - 83 citationsThe relative contribution of point mutations and genomic rearrangements in BRCA1 and BRCA2 in high risk breast cancer familiesMaurizia Dalla Palma, Susan M. Domchek, Jill Stopfer, Julie Erlichman, Jill D. Siegfried
Cancer Research. 2008-09-01 - 286 citationsA randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.John C. Ruckdeschel, Dianne M. Finkelstein, David S. Ettinger, Richard H. Creech, Bernard A. Mason
Journal of Clinical Oncology. 1986-01-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: